Evidence map›Paper›PMID 26854224›Full record

ArticleCell reports2016

RNF20 Links Histone H2B Ubiquitylation with Inflammation and Inflammation-Associated Cancer.

Ohad Tarcic, Ioannis S Pateras, Tomer Cooks, Efrat Shema, Julia Kanterman, Hadas Ashkenazi, Hana Boocholez, Ayala Hubert, Ron Rotkopf, Michal Baniyash and 3 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 90 papers.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

90 citing papers in PubMed, 138 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Decoding RNF20: an epigenetic modifier and beyond.Frontiers in cell and developmental biology · 2026
    Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Impact of Black Soldier Fly Larvae Oil on Immunometabolic Processes.International journal of molecular sciences · 2025
    Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. RNF20 contributes to epigenetic immunosuppression through CDK9-dependent LSD1 stabilization.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

Ohad TarcicDepartment of Molecular Cell Biology, The Weizmann Institute, Rehovot 7610001, Israel.
Ioannis S PaterasMolecular Carcinogenesis Group, Department of Histology-Embryology, School of Medicine, University of Athens, 11527 Athens, Greece.
Tomer CooksDepartment of Molecular Cell Biology, The Weizmann Institute, Rehovot 7610001, Israel.
Efrat ShemaDepartment of Molecular Cell Biology, The Weizmann Institute, Rehovot 7610001, Israel.
Julia KantermanThe Lautenberg Center for General and Tumor Immunology, Israel-Canada Medical Research Institute, Faculty of Medicine, The Hebrew University, Jerusalem 91120, Israel.
Hadas AshkenaziThe Lautenberg Center for General and Tumor Immunology, Israel-Canada Medical Research Institute, Faculty of Medicine, The Hebrew University, Jerusalem 91120, Israel.
Hana BoocholezThe Lautenberg Center for General and Tumor Immunology, Israel-Canada Medical Research Institute, Faculty of Medicine, The Hebrew University, Jerusalem 91120, Israel.
Ayala HubertSharett Institute of Oncology, Hebrew University-Hadassah Medical Center, Jerusalem 91120, Israel.
Ron RotkopfDepartment of Biological Services, Weizmann Institute of Science, Rehovot 7610001, Israel.
Michal BaniyashThe Lautenberg Center for General and Tumor Immunology, Israel-Canada Medical Research Institute, Faculty of Medicine, The Hebrew University, Jerusalem 91120, Israel.
Eli PikarskyDepartment of Immunology and Cancer Research, Hebrew University-Hadassah Medical School, Jerusalem 91120, Israel; Department of Pathology, Hebrew University-Hadassah Medical School, Jerusalem 91120, Israel.
Vassilis G GorgoulisMolecular Carcinogenesis Group, Department of Histology-Embryology, School of Medicine, University of Athens, 11527 Athens, Greece; Biomedical Research Foundation, Academy of Athens, 11527 Athens, Greece; Faculty Institute for Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Manchester M13 9WL, UK.
Moshe OrenDepartment of Molecular Cell Biology, The Weizmann Institute, Rehovot 7610001, Israel. Electronic address: moshe.oren@weizmann.ac.il.
Weizmann Institute of Science · ILHebrew University of Jerusalem · ILNational and Kapodistrian University of Athens · GRHadassah Medical Center · IL

Funding

Functional analysis of the p53 tumor suppressorR37CA040099 · NCI · WEIZMANN INSTITUTE OF SCIENCE · PI OREN, MOSHE · 2003 to 2012
$2.2M
NCI NIH HHS R37 CA040099NCI NIH HHS R37 CA40099
6 · The paper itself

Abstract

Factors linking inflammation and cancer are of great interest. We now report that the chromatin-targeting E3 ubiquitin ligase RNF20/RNF40, driving histone H2B monoubiquitylation (H2Bub1), modulates inflammation and inflammation-associated cancer in mice and humans. Downregulation of RNF20 and H2Bub1 favors recruitment of p65-containing nuclear factor κB (NF-κB) dimers over repressive p50 homodimers and decreases the heterochromatin mark H3K9me3 on a subset of NF-κB target genes to augment their transcription. Concordantly, RNF20(+/-) mice are predisposed to acute and chronic colonic inflammation and inflammation-associated colorectal cancer, with excessive myeloid-derived suppressor cells (MDSCs) that may quench antitumoral T cell activity. Notably, colons of human ulcerative colitis patients, as well as colorectal tumors, reveal downregulation of RNF20/RNF40 and H2Bub1 in both epithelium and stroma, supporting the clinical relevance of our tissue culture and mouse model findings.

Indexed as

Gene Expression Regulation, NeoplasticAnimalsChromatinColitis, UlcerativeColonColorectal NeoplasmsHistonesHumansInflammationMaleMiceMice, TransgenicMyeloid CellsNF-kappa BSignal TransductionT-LymphocytesChromatinHistonesNF-kappa BRNF20 protein, humanUbiquitin-Protein Ligases

Identifiers

PMID26854224
PMCPMC4761112
OpenAlexW2256276639

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.